BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN)

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 193,539,047
Number of holders: 381
Total 13F shares, excl. options: 161,240,868
Shares change: +1,588,523
Total reported value, excl. options: $16,892,503,727
Value change: +$165,350,997
Put/Call ratio: 83%
Number of buys: 181
Number of sells: -188
Price: $104.76

Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q4 2015

467 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q4 2015.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 381 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 161,240,868 shares of 193,539,047 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (17,988,101 shares), FMR LLC (14,609,839 shares), SANDS CAPITAL MANAGEMENT, LLC (11,637,466 shares), VANGUARD GROUP INC (11,195,877 shares), PRICE T ROWE ASSOCIATES INC /MD/ (8,026,813 shares), PRIMECAP MANAGEMENT CO/CA/ (7,330,689 shares), JENNISON ASSOCIATES LLC (6,691,351 shares), JPMORGAN CHASE & CO (5,630,593 shares), BAKER BROS. ADVISORS LP (4,115,083 shares), and BlackRock Institutional Trust Company, N.A. (3,831,966 shares).
This table shows the top 381 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.